TMCnet News
Research and Markets: The Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 Billion by 2017DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/3xzrsd/next_generation) has announced the addition of the "Next Generation Sequencing (NGS) Market - Global Forecast to 2017" report to their offering. This research report categorizes and analyzes the global Next Generation Sequencing (NGS) market on the basis of steps in the NGS workflow and NGS applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. The next generation sequencing (NSG) market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (ational Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms. Key Findings: - The NGS pre-sequencing (sample - preparation) segment represents a promising area in the overall market owing to the need for automation and standardized solutions for sample preparation. The market for sequencing platforms has been very dynamic. Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) have taken a setback and newer platforms like MiSeq and Ion Torrent Proton are gaining market dominance. - Along with large research and academic institutions that serve as a key end-user for the NGS market, NGS technologies are recently being developed for use in clinical set-ups and presently much of the NGS effort is focused on cancer. - The factors driving the NGS market include decreasing costs, improved turnaround time, increase in number of applications, and replacement of microarray applications by NGS. Personalized medicine and biomarker discovery open avenues for investments, thus offering a growth opportunity for the NGS market. However, the causes for hindrance to growth will be the high reliability on grants by research institutes, accuracy and standardization concerns, data storage problems, and issues in interpretation of complex data. Companies Mentioned: - Agilent Technologies (News - Alert), Inc - BGI (Beijing Genomics Institute) - Biomatters, Ltd - CLC Bio - Dnastar, Inc - EMC Corporation (News - Alert) - GATC biotech AG - Genomatix Software GMBH - Illumina, Inc - Knome, Inc - Life Sciences Corporation (A Roche Company) - Life Technologies Corporation - Macrogen, Inc - Ocimum Biosolutions, Ltd - Oxford Nanorpore Technologies, Ltd - Pacific Biosciences - Partek Incorporated - Perkinelmer, Inc - Qiagen NV - Strand Life Sciences Pvt Ltd For more information visit http://www.researchandmarkets.com/research/3xzrsd/next_generation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
